1. Home
  2. Stocks
  3. Par Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Par Drugs & Chemicals

    Small Cap
    ₹251.63
    -1.51 (-0.6%)
    27 July, 2024 07:31 BSE: NSE: PAR ISIN: INE04LG01015
    Bonus

    Start SIP in Par Drugs & Chemicals

    Start SIP

    Par Drugs & Chemicals Performance

    Day Range

    • Low 237
    • High 270
    ₹ 251

    52 Week Range

    • Low 178
    • High 325
    ₹ 251
    • Open Price270
    • Previous Close253
    • Volume49500

    Par Drugs & Chemicals Share Price

    • Over 1 Month + 10.57%
    • Over 3 Month -5.01%
    • Over 6 Month + 21.97%
    • Over 1 Year + 29.04%

    Par Drugs & Chemicals Key Statistics

    P/E Ratio 21.4
    PEG Ratio 0.8
    Market Cap Cr
    Price to Book Ratio 3.6
    EPS 11.8
    Dividend 0
    Relative Strength Index 63.25
    Money Flow Index 51.71
    MACD Signal 1.94
    Average True Range 11.12
    Par Drugs & Chemicals Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 2324262324
    Operating Expenses Qtr Cr 1719191919
    Operating Profit Qtr Cr 65745
    Depreciation Qtr Cr 11111
    Interest Qtr Cr 00000
    Tax Qtr Cr 11211
    Net Profit Qtr Cr 43523
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 9696
    Operating Expenses Annual Cr 7378
    Operating Profit Annual in Cr 2318
    Depreciation Cr 33
    Interest Annual Cr 00
    Tax Annual Cr 54
    Net Profit Annual Cr 1511
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 2013
    Cash from Investing Activity Annual Cr -6-7
    Cash from Financing Annual Activity Cr 0
    Net Cash Flow Annual Cr 146
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 8671
    Fixed Assets Annual Cr 4139
    Total Non Current Assets Annual Cr 4239
    Total Current Assets Annual Cr 6049
    Total Assets Annual Cr 10289
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 7058
    ROE Annual % 1716
    ROCE Annual % 2220
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2419
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Par Drugs & Chemicals

    Par Drugs & Chemicals Technicals

    EMA & SMA

    Current Price
    ₹251.63
    -1.51 (-0.6%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹240.84
    • 50 Day
    • ₹238.44
    • 100 Day
    • ₹234.72
    • 200 Day
    • ₹224.65
    • 20 Day
    • ₹241.27
    • 50 Day
    • ₹236.06
    • 100 Day
    • ₹237.06
    • 200 Day
    • ₹225.34

    Par Drugs & Chemicals Resistance and Support

    PIVOT
    ₹252.88
    Resistance
    First Resistance 268.75
    Second Resistance 285.88
    Third Resistance 301.75
    RSI 63.25
    MFI 51.71
    MACD Single Line 1.94
    MACD 3.42
    Support
    First Support 235.75
    Second Support 219.88
    Third Supoort 202.75

    Par Drugs & Chemicals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 49,500 2,167,110 43.78
    Week 44,100 2,457,671 55.73
    1 Month 40,043 2,118,257 52.9
    6 Month 59,756 2,433,259 40.72

    Par Drugs & Chemicals Result Highlights

    Par Drugs & Chemicals Synopsis

    NSE-Medical-Diversified

    Par Drugs & Chemical is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 95.64 Cr. and Equity Capital is Rs. 12.30 Cr. for the Year ended 31/03/2024. Par Drugs & Chemicals Ltd. is a Public Limited Listed company incorporated on 26/02/1999 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24117GJ1999PLC035512 and registration number is 035512.
    Market Cap 310
    Sales 96
    Shares in Float 0.32
    No of funds 3
    Yield 0.72
    Book Value 3.62
    U/D Vol ratio 1.1
    LTDebt / Equity
    Alpha 0.07
    Beta 0.45

    Par Drugs & Chemicals Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 74.21%74.21%74.21%74.21%
    Foreign Portfolio Investors 0.32%0.07%0.07%
    Individual Investors 20.09%20.45%21.23%21.4%
    Others 5.38%5.27%4.49%4.39%

    Par Drugs & Chemicals Management

    Name Designation
    Mr. Falgun Vallabhbhai Savani Chairman & Managing Director
    Mr. Jignesh Vallabhbhai Savani Executive Director & CEO
    Mr. Ghanshayambhai Bhagvanbhai Savani Whole Time Director
    Mrs. Nayna Jignesh Savani Non Executive Director
    Mr. Pravin Manjibhai Bhayani Independent Director
    Mrs. Kajal Chintanbhai Vaghani Independent Director
    Mr. Krishna Mitulbhai Shah Independent Director
    Mrs. Bintal Bhaveshkumar Shah Independent Director

    Par Drugs & Chemicals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Par Drugs & Chemicals Corporate Action

    Date Purpose Remarks
    2024-08-03 Quarterly Results
    2024-05-09 Audited Results & Others
    2024-02-16 Quarterly Results (Revised) issue in the ratio of 1:1 of Rs. 10/-.
    2023-10-28 Quarterly Results
    2023-08-03 Quarterly Results
    Date Purpose Remarks
    2021-04-28 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

    Par Drugs & Chemicals MF Shareholding

    Name Amount(cr)

    Par Drugs & Chemicals FAQs

    What is Share Price of Par Drugs & Chemicals ?

    Par Drugs & Chemicals share price is ₹251 As on 27 July, 2024 | 07:18

    What is the Market Cap of Par Drugs & Chemicals ?

    The Market Cap of Par Drugs & Chemicals is ₹309.6 Cr As on 27 July, 2024 | 07:18

    What is the P/E ratio of Par Drugs & Chemicals ?

    The P/E ratio of Par Drugs & Chemicals is 21.4 As on 27 July, 2024 | 07:18

    What is the PB ratio of Par Drugs & Chemicals ?

    The PB ratio of Par Drugs & Chemicals is 3.6 As on 27 July, 2024 | 07:18

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.